IDiyas

For the Inventor, By the Inventor

Madison, WI, United States of America

Donald T Witiak

USPTO Granted Patents = 27

Average Co-Inventor Count = 2.5

ph-index = 8

Forward Citations = 170(Granted Patents)


Location History:

  • Mount Vernon, OH (US) (1983 - 1985)
  • Vernon, OH (US) (1992)
  • Mt. Vernon, OH (US) (1987 - 1994)
  • late of Madison, WI (US) (2001)
  • Madison, WI (US) (1995 - 2002)
  • late of Mount Vernon, OH (US) (2003)

Company Filing History:

goldMedal18 out of 827 
 
The Ohio State University
 patents
silverMedal9 out of 4,119 
 
Wisconsin Alumni Research Foundation
 patents

Years Active: 1983-2003

Loading Chart...
27 patents (USPTO):Explore Patents
1. 6531499 - Matrix metalloproteinase inhibitors and method of using same (2003-03-11),
2. 6392098 - Conformationally restricted polyamines (2002-05-21),
3. 6294694 - Matrix metalloproteinase inhibitors and method of using same (2001-09-25),
4. 5977187 - 4-substituted-1,2-naphthoquinones and their use in the inhibition of (1999-11-02),
5. 5889061 - Conformationally restricted polyamines (1999-03-30),
6. 5883270 - 4-substituted-1, 2-naphthoquinones and their use in the inhibition of (1999-03-16),
7. 5866570 - Treatment of vascular leakage and related syndrome such as septic shock (1999-02-02),
8. 5824700 - Ortho-quinone derivatives novel synthesis therefor and their use in the (1998-10-20),
9. 5763625 - Synthesis and use of .beta.-lapachone analogs (1998-06-09),
10. 5656662 - Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic (1997-08-12),
11. 5504108 - Optically pure 4-aryl-2-hydroxytetronic acids (1996-04-02),
12. 5504107 - Optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids and (1996-04-02),
13. 5399721 - Synthesis of optically pure 4-aryl-2-hydroxytetronic acids (1995-03-21),
14. 5336796 - Diastereomeric mono- and di-substituted diamino cyclohexane compounds (1994-08-09),
15. 5298526 - Optically pure stereogenically labile 4-substituted-2-hydroxytetronic (1994-03-29),

Title: The Innovator Behind Matrix Metalloproteinase Inhibitors: A Profile of Donald T. Witiak

Introduction

Donald T. Witiak is a distinguished inventor based in Madison, Wisconsin, known for his significant contributions to the field of biochemistry and drug development. He holds an impressive portfolio of 27 patents, showcasing his innovative spirit and dedication to advancing scientific knowledge. His work primarily focuses on the development of pharmacological agents, particularly matrix metalloproteinase inhibitors, which have the potential to revolutionize treatments for various diseases.

Latest Patents

Among his latest patents, Witiak has introduced groundbreaking innovations such as "Matrix metalloproteinase inhibitors and method of using same" and "Conformationally restricted polyamines." These patents reflect his commitment to enhancing therapeutic strategies and improving patient outcomes through cutting-edge research.

Career Highlights

Witiak has made significant strides in his career, contributing his expertise to prominent research organizations. He has worked with esteemed institutions, including The Ohio State University Research Foundation and the Wisconsin Alumni Research Foundation, where he played a crucial role in various innovative projects. His contributions have helped pave the way for new treatments and advancements in pharmaceutical sciences.

Collaborations

Throughout his career, Witiak has collaborated with several notable professionals, including Benjamin J. Frydman and Laurence J. Marton. These partnerships have facilitated the exchange of innovative ideas and fostered the development of groundbreaking research in the fields of biochemistry and pharmacology.

Conclusion

In summary, Donald T. Witiak stands out as a prolific inventor and researcher whose work continues to impact the scientific community. His extensive patent portfolio and collaborations with leading organizations underscore his role as a key innovator in the development of novel therapeutic agents. As he continues to explore new frontiers in research and invention, Witiak’s contributions are sure to leave a lasting legacy in the realm of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…